Allgens(688613)2025-02-27 09:25Financial Performance - The total operating revenue for 2024 was CNY 205.76 million, a decrease of 9.15% compared to the previous year[3] - The net profit attributable to the parent company was CNY -18.12 million, a decline of 133.41% year-on-year[3] - The weighted average return on net assets was -1.31% for the reporting period[3] Assets and Liabilities - The company reported a total asset value of CNY 1,545.60 million at the end of the reporting period, an increase of 1.27% from the beginning of the period[5] - The company extended credit terms for distributors, resulting in an increase in accounts receivable aging over one year[7] Sales and Revenue Trends - The first quarter sales revenue was CNY 47.36 million, down 0.94% year-on-year, while the fourth quarter saw an increase of 33.96% to CNY 57.44 million[5] Research and Development - Research and development expenses totaled CNY 39.42 million during the reporting period[6] Strategic Initiatives - The company acquired HumanTech Dental in 2024 to expand into the dental implant business, which increased sales personnel and marketing expenses[6] Operational Challenges - The company faced significant operational challenges due to complex international and domestic economic conditions[5] - The gross profit margin decreased due to the implementation of centralized procurement policies, leading to lower factory prices[6]